Scarica l'app Stockscreener
21.48
0.00%
0.005
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AVDL Giù?
Forum
Previsione
Precedente Chiudi:
$21.48
Aprire:
$21.47
Volume 24 ore:
114.64K
Relative Volume:
0.04
Capitalizzazione di mercato:
$2.11B
Reddito:
$221.08M
Utile/perdita netta:
$-2.92M
Rapporto P/E:
-651.06
EPS:
-0.033
Flusso di cassa netto:
$5.89M
1 W Prestazione:
+0.59%
1M Prestazione:
+14.07%
6M Prestazione:
+117.19%
1 anno Prestazione:
+108.14%
Intervallo 1D:
$21.46
$21.55
Intervallo di 1 settimana:
$21.29
$21.55
Portata 52W:
$6.38
$23.57
Avadel Pharmaceuticals Plc Stock (AVDL) Company Profile
Nome
Avadel Pharmaceuticals Plc
Settore
Telefono
636-449-1830
Indirizzo
10 EARLSFORT TERRACE, DUBLIN 2
Confronta AVDL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AVDL
Avadel Pharmaceuticals Plc
|
21.49 | 2.11B | 221.08M | -2.92M | 5.89M | -0.033 |
|
ZTS
Zoetis Inc
|
118.39 | 52.03B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.50 | 45.40B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.63 | 42.13B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.71 | 34.19B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
484.33 | 20.88B | 3.08B | 1.24B | 1.07B | 25.61 |
Avadel Pharmaceuticals Plc Stock (AVDL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-23 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2025-09-03 | Iniziato | Wells Fargo | Equal Weight |
| 2025-07-18 | Ripresa | H.C. Wainwright | Buy |
| 2025-02-11 | Iniziato | Deutsche Bank | Buy |
| 2024-06-12 | Iniziato | Rodman & Renshaw | Buy |
| 2024-03-05 | Reiterato | H.C. Wainwright | Buy |
| 2024-03-05 | Reiterato | Needham | Buy |
| 2024-03-05 | Reiterato | Oppenheimer | Outperform |
| 2024-02-06 | Iniziato | UBS | Buy |
| 2022-11-30 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-08-10 | Downgrade | Jefferies | Buy → Hold |
| 2022-07-28 | Ripresa | Craig Hallum | Buy |
| 2022-05-26 | Downgrade | Stifel | Buy → Hold |
| 2021-09-23 | Iniziato | Needham | Buy |
| 2020-07-31 | Iniziato | Oppenheimer | Outperform |
| 2020-07-21 | Iniziato | SVB Leerink | Outperform |
| 2020-06-30 | Iniziato | H.C. Wainwright | Buy |
| 2020-04-03 | Iniziato | Jefferies | Buy |
| 2020-03-12 | Iniziato | Stifel | Buy |
| 2020-02-26 | Iniziato | Piper Sandler | Overweight |
| 2020-01-30 | Iniziato | Craig Hallum | Buy |
| 2019-06-14 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2019-02-08 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
Mostra tutto
Avadel Pharmaceuticals Plc Borsa (AVDL) Ultime notizie
Citadel Group discloses 1.24% stake in Avadel Pharmaceuticals - Investing.com
Geode Capital discloses 2.25% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Australia
Bank of America discloses 2% stake in Avadel Pharmaceuticals - Investing.com
Morgan Stanley reports trading activity in Avadel Pharmaceuticals shares - Investing.com
Citadel Group discloses 1.22% stake in Avadel Pharmaceuticals By Investing.com - Investing.com India
Goldman Sachs discloses trading position in Avadel Pharmaceuticals - Investing.com
Goldman Sachs discloses trading position in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Form 8.3Avadel Pharmaceuticals plc - The Manila Times
Janus Henderson discloses 3.73% stake in Avadel Pharmaceuticals - Investing.com
Janus Henderson discloses 3.73% stake in Avadel Pharmaceuticals By Investing.com - Investing.com South Africa
Morgan Stanley discloses dealings in Avadel Pharmaceuticals securities By Investing.com - Investing.com Australia
Morgan Stanley discloses dealings in Avadel Pharmaceuticals securities - Investing.com
Morgan Stanley discloses dealings in Avadel Pharmaceuticals shares By Investing.com - Investing.com South Africa
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals shares - Investing.com India
Morgan Stanley discloses dealings in Avadel Pharmaceuticals shares - Investing.com
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals shares By Investing.com - Investing.com Australia
Alkermes, Avadel Pharmaceuticals merger gets HSR clearance in US - MLex
Avadel Pharmaceuticals Acquisition by Alkermes Advances - TradingView
Trium Capital discloses 1.29% stake in Avadel Pharmaceuticals By Investing.com - Investing.com India
Citadel Group discloses 1.2% stake in Avadel Pharmaceuticals - Investing.com
Citadel Group discloses 1.2% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Canada
Goldman Sachs discloses trading activity in Avadel Pharmaceuticals By Investing.com - Investing.com South Africa
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Bank of America discloses 1.12% stake in Avadel Pharmaceuticals - Investing.com
Bank of America discloses 1.12% stake in Avadel Pharmaceuticals By Investing.com - Investing.com India
Morgan Stanley discloses trading in Avadel Pharmaceuticals shares By Investing.com - Investing.com South Africa
Morgan Stanley discloses trading in Avadel Pharmaceuticals shares - Investing.com
Morgan Stanley reports trading in Avadel Pharmaceuticals shares By Investing.com - Investing.com UK
FIL Limited discloses 2.9% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Canada
REGFIL Limited Avadel Pharma plcForm 8.3AVADEL PHARMACEUTICALS PLC - TradingView
Janus Henderson discloses 3.84% stake in Avadel Pharmaceuticals - Investing.com
Janus Henderson discloses 3.84% stake in Avadel Pharmaceuticals By Investing.com - Investing.com UK
Discipline and Rules-Based Execution in AVDL Response - news.stocktradersdaily.com
Avadel Pharmaceuticals PLC (AVDL) - MSN
How Recent Deal Developments Are Reshaping The Avadel Pharmaceuticals Investment Story - Yahoo Finance
Race For Avadel Heats Up: Alkermes Raises Offer To Secure $2.37B Deal After Lundbeck Challenge - MSN
Has Avadel’s 115% Rally in 2024 Already Priced In Its Narcolepsy Breakthrough? - Yahoo Finance
Avadel Pharmaceuticals plc and Alkermes plc Announce Proposed Transaction for Acquisition - Quiver Quantitative
Announcement relating to despatch of Rule 15 proposal - The Manila Times
Avadel (NASDAQ: AVDL) sends Rule 15 proposal to equity holders in Alkermes deal - Stock Titan
Trium Capital discloses 1.16% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Australia
Trium Capital discloses 1.16% stake in Avadel Pharmaceuticals - Investing.com
Geode Capital Management discloses 2.23% stake in Avadel Pharmaceuticals - Investing.com
Geode Capital Management discloses 2.23% stake in Avadel Pharmaceuticals By Investing.com - Investing.com South Africa
Avadel Pharmaceuticals PLC. $AVDL Shares Acquired by Two Seas Capital LP - MarketBeat
How Avadel Pharmaceuticals plc (AWK) stock responds to bond marketIPO Watch & Weekly High Return Opportunities - Newser
Bank of America discloses 0.975% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Australia
What dividend safety rating applies to Avadel Pharmaceuticals plc (AWK) stock2025 Institutional Moves & Real-Time Volume Analysis - Newser
Kennedy Capital Management LLC Raises Stake in Avadel Pharmaceuticals PLC. $AVDL - MarketBeat
Avadel Pharmaceuticals Plc Azioni (AVDL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Avadel Pharmaceuticals Plc Azioni (AVDL) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Thornton Peter J. | Director |
Jan 13 '25 |
Buy |
8.04 |
10,000 |
80,450 |
104,055 |
| Ende Eric J | Director |
Jan 13 '25 |
Buy |
7.84 |
30,000 |
235,218 |
208,900 |
| MCHUGH THOMAS S | Chief Financial Officer |
Dec 13 '24 |
Buy |
10.44 |
2,300 |
24,019 |
87,800 |
2.31%
0.66%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):